Hormonal therapy after stem cell transplantation and risk of veno-occlusive disease.


The elegant report from Hagglund et al1 recently published in Blood raises a very important ethical issue in clinical hematology practice: primum non nocere. The authors describe the impact of norethisterone treatment, routinely used in the prevention of menstrual bleeding in women submitted to allogeneic bone marrow transplantation, on veno-occlusive… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics